These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12548568)

  • 1. Third North American Symposium on Skeletal Complications of Malignancy: summary of the scientific sessions.
    Mohla S; Weilbacher KN; Cher ML; Oyajobi BO; Poznak CV; Clohisy DR
    Cancer; 2003 Feb; 97(3 Suppl):719-25. PubMed ID: 12548568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
    Ibrahim A; Scher N; Williams G; Sridhara R; Li N; Chen G; Leighton J; Booth B; Gobburu JV; Rahman A; Hsieh Y; Wood R; Vause D; Pazdur R
    Clin Cancer Res; 2003 Jul; 9(7):2394-9. PubMed ID: 12855610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local effects of malignancy on bone.
    Brown SA; Clines GA; Guise TA
    Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):436-41. PubMed ID: 17982348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Bisphosphonates in the therapy of cancer patients].
    Jantunen E; Kumpulainen E
    Duodecim; 1999; 115(1):27-32. PubMed ID: 11830857
    [No Abstract]   [Full Text] [Related]  

  • 5. How can we improve the treatment of bone metastases further?
    Coleman RE
    Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S7-13. PubMed ID: 9801853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone metastases in breast cancer, prostate cancer and myeloma.
    Paterson AH
    Bone; 1987; 8 Suppl 1():S17-22. PubMed ID: 3318889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should bisphosphonates be part of the standard therapy of patients with multiple myeloma or bone metastases from other cancers? An evidence-based review.
    Bloomfield DJ
    J Clin Oncol; 1998 Mar; 16(3):1218-25. PubMed ID: 9508210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal Complications of Malignancy. Proceedings of a symposium. Bethesda, Maryland, April 19-20, 1997.
    Cancer; 1997 Oct; 80(8 Suppl):1527-701. PubMed ID: 9377495
    [No Abstract]   [Full Text] [Related]  

  • 9. Abstracts of the 3rd North American Symposium on Skeletal Complications of Malignancy. April 2002, Bethesda, Maryland, USA.
    Oncology (Williston Park); 2003 Apr; 17(4 Suppl 3):9-54. PubMed ID: 12757009
    [No Abstract]   [Full Text] [Related]  

  • 10. Bisphosphonates--role in cancer therapies.
    Mehrotra B
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):19-26. PubMed ID: 19371811
    [No Abstract]   [Full Text] [Related]  

  • 11. Bisphosphonates in the prevention and treatment of bone metastases.
    Ramaswamy B; Shapiro CL
    Oncology (Williston Park); 2003 Sep; 17(9):1261-70; discussion 1270-2, 1277-8, 1280. PubMed ID: 14569853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of bisphosphonates in patients with breast cancer.
    Van Poznak CH
    Cancer Control; 2002; 9(6):480-9. PubMed ID: 12514566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral bisphosphonates: A review of clinical use in patients with bone metastases.
    Major PP; Lipton A; Berenson J; Hortobagyi G
    Cancer; 2000 Jan; 88(1):6-14. PubMed ID: 10618600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bisphosphonates in multiple myeloma: current status; future perspectives.
    Jantunen E; Laakso M
    Br J Haematol; 1996 Jun; 93(3):501-6. PubMed ID: 8652366
    [No Abstract]   [Full Text] [Related]  

  • 15. Pathophysiology of bone metastases: how this knowledge may lead to therapeutic intervention.
    Lipton A
    J Support Oncol; 2004; 2(3):205-13; discussion 213-4, 216-7, 219-20. PubMed ID: 15328823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ; Mancini I
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone continuum of cancer.
    Lipton A
    Am J Clin Oncol; 2010 Jun; 33(3 Suppl):S1-7. PubMed ID: 20526089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effects and anticancer applications of bisphosphonates.
    Morgan G; Lipton A
    Semin Oncol; 2010 Oct; 37 Suppl 2():S30-40. PubMed ID: 21111246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness and cost of bisphosphonate therapy in tumor bone disease.
    Body JJ
    Cancer; 2003 Feb; 97(3 Suppl):859-65. PubMed ID: 12548587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid treatment at home: safety data from an observational prospective trial.
    Tassinari D; Poggi B; Nicoletti S; Fantini M; Tamburini E; Possenti C; Sartori S
    J Palliat Med; 2007 Apr; 10(2):352-8. PubMed ID: 17472506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.